Mehdi Gasmi Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mehdi Gasmi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mehdi Gasmi. Mehdi Gasmi is Chief Science & Tech Officer in Adverum Biotechnologies, Inc. ($AAVL) and Chief Scientific Officer in Adverum Biotechnologies, Inc. ($AAVL) and Director in Adverum Biotechnologies, Inc. ($ADVM) and President and CSO in Adverum Biotechnologies, Inc. ($ADVM) and SVP,Pharmaceutical Development in Adverum Biotechnologies, Inc. ($AAVL) and VP, Pharmaceutical Development in Adverum Biotechnologies, Inc. ($AAVL).
Latest Insider Trading Transactions of Mehdi Gasmi
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 78,000 | |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 17.60 | 5,000 | 87,978 | 274,442 | 279.4 K to 274.4 K (-1.79 %) |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 279,442 | 274.4 K to 279.4 K (+1.82 %) |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 78,000 | |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 17.60 | 5,000 | 87,978 | 274,442 | 279.4 K to 274.4 K (-1.79 %) |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 279,442 | 274.4 K to 279.4 K (+1.82 %) |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 23,605 | 113,304 | 83,000 | |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.06 | 23,605 | 591,617 | 274,442 | 298 K to 274.4 K (-7.92 %) |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 23,605 | 113,304 | 298,047 | 274.4 K to 298 K (+8.60 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 11,127 | 53,410 | 106,605 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 11,127 | 53,410 | 106,605 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 268 | 1,286 | 117,732 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 268 | 1,286 | 117,732 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 11,127 | 278,329 | 274,442 | 285.6 K to 274.4 K (-3.90 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 11,127 | 278,329 | 274,442 | 285.6 K to 274.4 K (-3.90 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 11,127 | 53,410 | 285,569 | 274.4 K to 285.6 K (+4.05 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 11,127 | 53,410 | 285,569 | 274.4 K to 285.6 K (+4.05 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 268 | 6,703 | 274,442 | 274.7 K to 274.4 K (-0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 268 | 6,703 | 274,442 | 274.7 K to 274.4 K (-0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 268 | 1,286 | 274,710 | 274.4 K to 274.7 K (+0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 268 | 1,286 | 274,710 | 274.4 K to 274.7 K (+0.10 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 118,000 | |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 23.59 | 159 | 3,751 | 274,442 | 274.6 K to 274.4 K (-0.06 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 23.00 | 3,425 | 78,787 | 274,601 | 278 K to 274.6 K (-1.23 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 21.93 | 1,416 | 31,047 | 278,026 | 279.4 K to 278 K (-0.51 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 21.01 | 5,000 | 105,042 | 279,442 | 284.4 K to 279.4 K (-1.76 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 284,442 | 274.4 K to 284.4 K (+3.64 %) |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 3,599 | 17,275 | 128,000 | |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 1,401 | 6,725 | 131,599 | |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | S | 20.02 | 3,599 | 72,048 | 274,442 | 270.8 K to 274.4 K (+1.33 %) |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 3,599 | 17,275 | 278,041 | 274.4 K to 278 K (+1.31 %) |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 20.01 | 1,401 | 28,030 | 274,442 | 275.8 K to 274.4 K (-0.51 %) |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 1,401 | 6,725 | 275,843 | 274.4 K to 275.8 K (+0.51 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 133,000 | |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 25,000 | 120,000 | 138,000 | |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 163,000 | |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 19.03 | 300 | 5,709 | 274,442 | 274.7 K to 274.4 K (-0.11 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 18.11 | 4,700 | 85,124 | 274,742 | 279.4 K to 274.7 K (-1.68 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 279,442 | 274.4 K to 279.4 K (+1.82 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 20.03 | 25,000 | 500,668 | 274,442 | 299.4 K to 274.4 K (-8.35 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 25,000 | 120,000 | 299,442 | 274.4 K to 299.4 K (+9.11 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 16.26 | 10,000 | 162,573 | 274,442 | 284.4 K to 274.4 K (-3.52 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 284,442 | 274.4 K to 284.4 K (+3.64 %) |
| Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 173,000 | |
| Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 16.23 | 5,000 | 81,156 | 258,979 | 264 K to 259 K (-1.89 %) |
| Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 263,979 | 259 K to 264 K (+1.93 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 178,000 | |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 15.07 | 10,000 | 150,690 | 258,979 | 269 K to 259 K (-3.72 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 268,979 | 259 K to 269 K (+3.86 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 15.05 | 15,494 | 233,185 | 258,979 | 274.5 K to 259 K (-5.64 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 11.33 | 31,451 | 356,340 | 289,967 | 321.4 K to 290 K (-9.79 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Grant | A | 0.00 | 88,496 | 0 | 321,418 | 232.9 K to 321.4 K (+37.99 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 10.24 | 11,551 | 118,282 | 309,867 | 321.4 K to 309.9 K (-3.59 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 5.98 | 589 | 3,522 | 321,418 | 322 K to 321.4 K (-0.18 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.55 | 10,652 | 37,815 | 322,007 | 332.7 K to 322 K (-3.20 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.33 | 12,599 | 41,955 | 332,659 | 345.3 K to 332.7 K (-3.65 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 6.30 | 605 | 3,812 | 247,762 | 248.4 K to 247.8 K (-0.24 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 6.85 | 10,806 | 74,021 | 248,367 | 259.2 K to 248.4 K (-4.17 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 7.05 | 11,433 | 80,603 | 259,173 | 270.6 K to 259.2 K (-4.22 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 2.50 | 5,479 | 13,698 | 270,606 | 276.1 K to 270.6 K (-1.98 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 2.70 | 657 | 1,774 | 276,085 | 276.7 K to 276.1 K (-0.24 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.00 | 12,793 | 38,379 | 276,742 | 289.5 K to 276.7 K (-4.42 %) |
| Feb 19 2019 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | President and CSO | Option Exercise | A | 3.50 | 225,000 | 787,500 | 225,000 | |
| Jun 18 2018 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Chief Science & Tec ... | Grant | A | 0.00 | 88,496 | 0 | 387,031 | 298.5 K to 387 K (+29.64 %) |
| Feb 20 2018 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Chief Science & Tec ... | Option Exercise | A | 6.40 | 160,000 | 1,024,000 | 160,000 | |
| Feb 13 2017 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Science & Tec ... | Option Exercise | A | 2.70 | 181,000 | 488,700 | 181,000 | |
| Feb 13 2017 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Science & Tec ... | Grant | A | 0.00 | 125,000 | 0 | 289,535 | 164.5 K to 289.5 K (+75.97 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Scientific Of ... | Option Exercise | A | 4.80 | 188,000 | 902,400 | 188,000 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Scientific Of ... | Grant | A | 0.00 | 125,000 | 0 | 161,803 | 36.8 K to 161.8 K (+339.65 %) |
| Aug 25 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Scientific Of ... | Grant | A | 0.00 | 29,160 | 0 | 36,160 | 7 K to 36.2 K (+416.57 %) |
| Jun 17 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | SVP,Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 95,000 | |
| Jun 17 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | SVP,Pharmaceutical ... | Sell | S | 39.86 | 500 | 19,931 | 7,000 | 7.5 K to 7 K (-6.67 %) |
| Jun 17 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | SVP,Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 95,500 | |
| Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 39.88 | 82 | 3,270 | 7,000 | 7.1 K to 7 K (-1.16 %) |
| Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.95 | 183 | 7,128 | 7,082 | 7.3 K to 7.1 K (-2.52 %) |
| Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 37.97 | 235 | 8,923 | 7,265 | 7.5 K to 7.3 K (-3.13 %) |
| Jun 10 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| May 29 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 96,000 | |
| May 29 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.02 | 500 | 19,009 | 7,000 | 7.5 K to 7 K (-6.67 %) |
| May 29 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| May 22 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 96,500 | |
| May 22 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.87 | 500 | 19,435 | 7,000 | 7.5 K to 7 K (-6.67 %) |
| May 22 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| May 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 97,000 | |
| May 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 35.31 | 500 | 17,656 | 7,000 | 7.5 K to 7 K (-6.67 %) |
| May 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| May 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 500 | 1,375 | 97,500 | |
| May 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 33.28 | 500 | 16,638 | 7,000 | 7.5 K to 7 K (-6.67 %) |
| May 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 500 | 1,375 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| Apr 30 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 1,000 | 2,750 | 98,000 | |
| Apr 30 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 35.67 | 1,000 | 35,667 | 7,000 | 8 K to 7 K (-12.50 %) |
| Apr 30 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 1,000 | 2,750 | 8,000 | 7 K to 8 K (+14.29 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | A | 39.35 | 20,000 | 787,000 | 20,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 1,000 | 2,750 | 99,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Grant | A | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 39.21 | 1,000 | 39,211 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 1,000 | 2,750 | 1,000 | 0 to 1,000 |
| Apr 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 1,000 | 2,750 | 100,000 | |
| Apr 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 39.45 | 1,000 | 39,448 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 15 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 1,000 | 2,750 | 1,000 | 0 to 1,000 |
| Apr 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | M | 2.75 | 9,000 | 24,750 | 101,000 | |
| Apr 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 39.06 | 292 | 11,406 | 0 | 292 to 0 (-100.00 %) |
| Apr 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Sell | S | 38.59 | 8,708 | 336,019 | 292 | 9 K to 292 (-96.76 %) |
| Apr 08 2015 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Buy | M | 2.75 | 9,000 | 24,750 | 9,000 | 0 to 9 K |
| Aug 01 2014 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | VP, Pharmaceutical ... | Option Exercise | A | 17.00 | 70,000 | 1,190,000 | 70,000 |
Page: 1